High-dose ifosfamide and mitoxantrone (HDIM) in patients with relapsed or refractory Hodgkin's lymphoma.
Saved in:
| Title: | High-dose ifosfamide and mitoxantrone (HDIM) in patients with relapsed or refractory Hodgkin's lymphoma. |
|---|---|
| Authors: | Aurer, Igor aurer@mef.hr, Nemet, Damir, Mitrović, Zdravko1, Dujmović, Dino1, Bašić-Kinda, Sandra2, Radman, Ivo2, Sertić, Dubravka2, Šantek, Fedor, Kralik, Marko3, Dotlić, Snježana4, Mazić, Sanja5, Labar, Boris, Mitrović, Zdravko6 (AUTHOR), Dujmović, Dino6 (AUTHOR), Bašić-Kinda, Sandra7 (AUTHOR), Sertić, Dubravka7 (AUTHOR), Šantek, Fedor6,8 (AUTHOR), Dotlić, Snježana9 (AUTHOR), Mazić, Sanja10 (AUTHOR) |
| Source: | Annals of Hematology. Jun2016, Vol. 95 Issue 7, p1129-1136. 8p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!